, Volume 65, Issue 4, pp 723–729 | Cite as

Investigations on the liquid crystalline phases of cation-induced condensed DNA

  • C. K. S. Pillai
  • Neethu Sundaresan
  • M. Radhakrishnan Pillai
  • T. Thomas
  • T. J. Thomas


Viral and nonviral condensing agents are used in gene therapy to compact oligonucleotides and plasmid DNA into nanostructures for their efficient transport through the cell membranes. Whereas viral vectors are best by the toxic effects on the immune system, most of the nonviral delivery vehicles are not effective for use in clinical system. Recent investigations indicate that the supramolecular organization of DNA in the condensed state is liquid crystalline. The present level of understanding of the liquid crystalline phase of DNA is inadequate and a thorough investigation is required to understand the nature, stability, texture and the influence of various environmental conditions on the structure of the phase. The present study is mainly concerned with the physicochemical investigations on the liquid crystalline transitions during compaction of DNA by cationic species such as polyamines and metallic cations. As a preliminary to the above investigation, studies were conducted on the evolution of mesophase transitions of DNA with various cationic counterion species using polarized light microscopy. These studies indicated significant variations in the phase behaviour of DNA in the presence of Li and other ions. Apart from the neutralization of the charges on the DNA molecule, these ions are found to influence selectively the hydration sphere of DNA that in turn influences the induction and stabilization of the LC phases. The higher stability observed with the liquid crystalline phases of Li-DNA system could be useful in the production of nanostructured DNA. In the case of the polyamine, a structural specificity effect depending on the nature, charge and structure of the polyamine used has been found to be favoured in the crystallization of DNA.


Liquid crystalline DNA alkali metal ions DNA condensation nanostructured DNA 


61.30.-v 71.20.Dg 87.14.Gg 81.16.Rf 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. [1]
    L M Santhakumaran, A Chen, C K S Pillai, T Thomas, H X He and T J Thomas,Nanofabrication for biomedical applications edited by J Hormes, C Kumar and C Leuschner (Wiley-VCH, New York, 2004) pp. 253–287Google Scholar
  2. [2]
    V Vijayanathan, T Thomas and T J Thomas,Biochemistry 41, 14085 (2002)CrossRefGoogle Scholar
  3. [3]
    V Vijayanathan, T Thomas, T Antony, A Shirahata and T J Thomas,Nucl. Acids Res. 32, 127 (2004)CrossRefGoogle Scholar
  4. [4]
    M Saminathan, T Thomas, A Shirahata, C K S Pillai and T J Thomas,Nucl. Acids Res. 30, 3722 (2002)CrossRefGoogle Scholar
  5. [5]
    V Vijayanathan, J Lyall, T Thomas, A Shirahata and T J Thomas,Biomacromolecules 6, 1097 (2005)CrossRefGoogle Scholar
  6. [6]
    V A Bloomfield,Biopolymers 44, 269 (1997)CrossRefGoogle Scholar
  7. [7]
    F Livolant and A Leforestier,Prog. Polym. Sci. 21, 1115 (1996)CrossRefGoogle Scholar
  8. [8]
    T Blessing, J S Remy and J P Behr,Proc. Natl. Acad. Sci. USA 95, 1427 (1998)CrossRefADSGoogle Scholar
  9. [9]
    R L Rill, P R Hilliard and G C Levy,J. Biol. Chem. 258, 250 (1983)Google Scholar
  10. [10]
    N V Hud and K H Downing,Proc. Natl. Acad. Sci. USA 98, 14925 (2001)CrossRefADSGoogle Scholar
  11. [11]
    J Torbet and E DiCapua,Eur. Mol. Biol. Org. J. 8, 4351 (1989)Google Scholar

Copyright information

© Indian Academy of Sciences 2005

Authors and Affiliations

  • C. K. S. Pillai
    • 1
  • Neethu Sundaresan
    • 1
  • M. Radhakrishnan Pillai
    • 2
  • T. Thomas
    • 3
  • T. J. Thomas
    • 3
  1. 1.Regional Research LaboratoryThiruvananthapuramIndia
  2. 2.Rajeev Gandhi Centre for BiotechnologyThiruvananthapuramIndia
  3. 3.Departments of Medicine and Environmental and Community MedicineUniversity of Medicine and Dentistry, Robert Wood Johnson Medical SchoolUSA

Personalised recommendations